A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2, 3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule

Jing Ping Liou, Kuo Shun Hsu, Ching Chuan Kuo, Chi Yen Chang, Jang Yang Chang

Research output: Contribution to journalArticlepeer-review

60 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2, 3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule'. Together they form a unique fingerprint.

Medicine & Life Sciences